Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
about
Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding proteinBiomarkers of Nutrition for Development (BOND)-Vitamin A ReviewVitamin A Transport Mechanism of the Multitransmembrane Cell-Surface Receptor STRA6Retina, retinol, retinal and the natural history of vitamin A as a light sensorIntracellular transport of fat-soluble vitamins A and EStructural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding proteinHydrophobic ligand binding properties of the human lipocalin apolipoprotein MLiver retinol transporter and receptor for serum retinol-binding protein (RBP4)Vitamin A transport and the transmembrane pore in the cell-surface receptor for plasma retinol binding proteinIsoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liverInhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturaRetinoid-binding proteins: similar protein architectures bind similar ligands via completely different ways.Retinoid pathway and cancer therapeuticsSynthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.Recent advances in transthyretin amyloidosis therapyRetinol-binding protein 4 levels and susceptibility to ischaemic events in men.Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives.Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses.Real-time analyses of retinol transport by the membrane receptor of plasma retinol binding protein.Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome.Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity.Vitamin A derivatives as treatment options for retinal degenerative diseases.Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acidsSTRA6-catalyzed vitamin A influx, efflux, and exchange.Differential and isomer-specific modulation of vitamin A transport and the catalytic activities of the RBP receptor by retinoidsSerum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional studyTechniques to study specific cell-surface receptor-mediated cellular vitamin A uptake.The membrane receptor for plasma retinol-binding protein, a new type of cell-surface receptor.Mapping the membrane topology and extracellular ligand binding domains of the retinol binding protein receptor.Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.Urinary biomarkers for acute kidney injury in dogs.An essential ligand-binding domain in the membrane receptor for retinol-binding protein revealed by large-scale mutagenesis and a human polymorphism.Receptor-mediated cellular uptake mechanism that couples to intracellular storage.Current and future treatment of amyloid diseases.Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation.Panel-based whole exome sequencing identifies novel mutations in microphthalmia and anophthalmia patients showing complex Mendelian inheritance patterns.Increasing the length and hydrophobicity of the C-terminal sequence of transthyretin strengthens its binding affinity to retinol binding protein.Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
P2860
Q24315891-EF76F526-2E2F-4630-AEB2-2718535FD036Q26741961-8D589C81-BD7A-4F36-8441-04B624455C54Q26783584-EA6E05A7-5D05-48A8-B2DA-DE886BE63531Q26998937-A511DFFA-D98B-43C7-8852-0C060931D7B8Q27000172-FF23D156-F3C8-409D-B1AB-3849A101BA4FQ27652955-5C090136-15A4-415B-B55F-A34401543CAFQ28303846-2D3293CB-8683-42D4-B0E0-B84BD400D354Q28512269-2C72AF0F-CA27-43B8-83FB-5DFA6C7C368AQ28534788-BE273C96-659F-4477-AFC3-41E9BC963BADQ33364279-DD6F68B5-35B3-4B6C-8D66-EDB395A7B2E3Q33610379-69AC35A6-AC85-4DCD-8A77-DB5FBF21C167Q34264954-6E7C34D8-5F9A-46A3-9A11-46AB2746DCFCQ34348117-41F1588B-CAE7-4733-B9AC-DF27C1DDF703Q34601105-B186B850-31E2-4389-A301-0BD2C4D5E65BQ34664696-7E75C59C-0883-4997-8F03-4C8A09940FEAQ35144562-C2D7F011-9C90-4B17-930B-219323970C3DQ35567312-C0F98971-30D8-4FAF-A6EA-48AB348645DDQ36475069-B1A26138-3BC0-4640-B602-F0C954FF67A8Q36639523-662DEFBC-BF60-4A37-B75E-0A1F45975ABFQ36793921-B57135B4-BA10-473C-A1C7-05B8A3C9840BQ37083027-0BB7FEB4-4F8C-4C00-9DA1-81B177938B22Q37083819-2D4C1B37-BABC-4169-AF23-3A5D86C5DC2FQ37132869-9B8D1D7A-439E-40A1-A10C-789100A71449Q37164056-1A6A40B5-0B04-407B-B5D8-7FD82CB72318Q37184481-654FEF18-33F4-4F82-9A95-F784AA13609CQ37418334-57DA0BBD-DD2E-4663-8EA5-ACC97F046E20Q37533312-39E34FFB-0E65-41A7-A9AF-223953055A94Q37533328-E02BE71E-D701-464D-88D2-0B7F53579C1AQ37533333-0299E61A-3637-44E5-AAEE-67E830C4B40FQ37601036-C9F04129-4401-46C4-8FED-466E1B862A53Q37975816-364C1DAD-222F-486C-BDA8-E13E0320B4A9Q38129441-68121883-98B2-4B9D-B4C0-A5817DAEC186Q38631656-C72F1CFA-4DFA-485F-A9BD-C077FE8AAA4EQ38793331-67D70336-AA78-46A8-8673-C4FE7B75634FQ38831388-CEF3A837-6FED-48A8-9BD2-4FC524B1B3F2Q41952325-9889DEA1-7CFD-465C-8EA6-5924D4B46C93Q42050715-9673B009-1F72-487D-8873-7BE7A5BB3874Q47100462-8DE53BA7-A7BE-421D-8E24-617E432564BCQ47160016-3BA293E2-1BE2-4387-A38A-4F2B1C29D521Q53684493-4FDCCD1A-2D8E-4C3C-BCDF-2E1DCF5CA604
P2860
Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@ast
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@en
type
label
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@ast
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@en
prefLabel
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@ast
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@en
P1476
Plasma retinol-binding protein ...... retinoids, and transthyretin.
@en
P2093
Giuseppe Zanotti
Rodolfo Berni
P304
P356
10.1016/S0083-6729(04)69010-8
P577
2004-01-01T00:00:00Z